Skip to content

EFFECTS OF PATIENT-CENTERED PHARMACEUTICAL CARE ON DRUG THERAPY AND HEALTH -RELATED QUALITY OF LIFE AND MEDICATION ADHERENCE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

EFFECTS OF PATIENT-CENTERED PHARMACEUTICAL CARE ON DRUG THERAPY AND HEALTH -RELATED QUALITY OF LIFE AND MEDICATION ADHERENCE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220701001
Enrollment
326
Registered
2022-07-01
Start date
2022-06-27
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depressive disorder major depressive disorder MDD

Interventions

Patient-centered pharmaceutical care - First visit: Provide patient-centered pharmaceutical care : 1)Assess the patient medical problems, 2) develope care plan 3) psychoeducation - Follow up (1 week l
Patient-centered pharmaceutical care,Usual care

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosed as major depressive disorder according to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V), 2. Treated with antidepressants for at least 2 weeks, 3. Take medicine by himself, 4. Thai who can communicate and read Thai language, 5. Follow-up date is within 4 to 5 weeks.

Exclusion criteria

Exclusion criteria: 1. Treated with other treatment i.e. CBT or ECT, 2. Diagnosed as other psychiatric disorders i.e. anxiety disorder schizophrenia, 3.Cognitive impairment (TMSE<=23), 4.Diagnosed as other chronic diease and are not stable, 5. Can not contact via a telephone, 6. Can not complete the questionnaire at the first time

Design outcomes

Primary

MeasureTime frame
Drug therapy-related quality of life at 4-5 weeks after Intervention Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QoL)-modified,Medication adherence at 4-5 weeks after Intervention MTB-Thai,Health-related quality of life at 4-5 weeks after intervention EQ-5D-5L

Secondary

MeasureTime frame
Depression symptoms at 4-5 weeks after Intervention 9Q

Countries

Thailand

Contacts

Public ContactPimpaka Sunthi

Somdet Chaopraya Institute of Psychiatry

pimpaka.sthi@gmail.com0841690508

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026